Ryota Kuroki

Title: Ryota Kuroki: Innovator in Immunology

Introduction

Ryota Kuroki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of immunology, particularly through his innovative research and patents. His work focuses on the development of glycosylation inhibiting factors that have potential applications in immunosuppressive therapies.

Latest Patents

Kuroki holds a patent for "Antigen non-specific glycosylation inhibiting factor derivatives." This patent describes antigen non-specific human glycosylation inhibiting factor derivatives that possess immunosuppressive activity. The invention involves introducing mutations for replacement, deletion, and/or insertion of parts of the amino acid sequence of SEQ ID NO:21. Additionally, it includes chemical modifications of one or more amino acid residues in the sequence, which attenuate the strength of intermolecular associations that participate in trimerization. The patent also covers DNAs encoding the amino acid sequence, recombinant vectors, transformed prokaryotic or eukaryotic cells, methods of producing the derivatives, pharmaceutical compositions, and methods for suppressing human immune responses to antigens.

Career Highlights

Ryota Kuroki is affiliated with the La Jolla Institute for Allergy and Immunology, where he conducts his research. His work has garnered attention for its potential impact on immunotherapy and related fields. Kuroki's innovative approach to glycosylation inhibition is paving the way for new therapeutic strategies.

Collaborations

Kuroki collaborates with notable colleagues, including Toshifumi Mikayama and Takafumi Tomura. Their combined expertise enhances the research efforts at the La Jolla Institute for Allergy and Immunology.

Conclusion

Ryota Kuroki is a key figure in the field of immunology, with a focus on glycosylation inhibiting factors. His patent and research contributions are significant steps toward advancing immunosuppressive therapies. His work continues to inspire innovation in the medical field.